These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32145868)

  • 1. Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment.
    Cheung CC; Roston TM; Andrade JG; Bennett MT; Davis MK
    Can J Cardiol; 2020 Mar; 36(3):416-423. PubMed ID: 32145868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Implantable Electronic Devices in Patients With Cardiac Amyloidosis.
    John RM; Stern DL
    Can J Cardiol; 2020 Mar; 36(3):408-415. PubMed ID: 32037105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities.
    Falk RH; Rubinow A; Cohen AS
    J Am Coll Cardiol; 1984 Jan; 3(1):107-13. PubMed ID: 6317729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.
    El-Am EA; Dispenzieri A; Melduni RM; Ammash NM; White RD; Hodge DO; Noseworthy PA; Lin G; Pislaru SV; Egbe AC; Grogan M; Nkomo VT
    J Am Coll Cardiol; 2019 Feb; 73(5):589-597. PubMed ID: 30732713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic conduction system disease in cardiac amyloidosis.
    Mathew V; Olson LJ; Gertz MA; Hayes DL
    Am J Cardiol; 1997 Dec; 80(11):1491-2. PubMed ID: 9399732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis.
    Bukhari S; Khan B
    J Cardiol; 2023 May; 81(5):429-433. PubMed ID: 36894119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Arrhythmias in Cardiac Amyloidosis.
    Giancaterino S; Urey MA; Darden D; Hsu JC
    JACC Clin Electrophysiol; 2020 Apr; 6(4):351-361. PubMed ID: 32327068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis.
    Rehorn MR; Loungani RS; Black-Maier E; Coniglio AC; Karra R; Pokorney SD; Khouri MG
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1144-1154. PubMed ID: 32972550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death.
    Lin G; Dispenzieri A; Brady PA
    Eur Heart J; 2010 Jun; 31(12):1538. PubMed ID: 20061577
    [No Abstract]   [Full Text] [Related]  

  • 13. Bradyarrhythmias in Cardiac Amyloidosis and Role of Pacemaker.
    Bukhari S; Kasi A; Khan B
    Curr Probl Cardiol; 2023 Nov; 48(11):101912. PubMed ID: 37392977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmias and Device Therapies in Cardiac Amyloidosis.
    Bukhari S; Khan SZ; Ghoweba M; Khan B; Bashir Z
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.
    Patel KS; Hawkins PN; Whelan CJ; Gillmore JD
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25535224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis.
    Ashraf I; Peck MM; Maram R; Mohamed A; Ochoa Crespo D; Kaur G; Malik BH
    Cureus; 2020 Aug; 12(8):e9842. PubMed ID: 32953349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmia risk stratification in patients with heart failure. Foreword].
    Opasich C; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arrhythmias].
    Misaki T; Fukahara K
    Kyobu Geka; 2004 Jul; 57(8 Suppl):729-35. PubMed ID: 15362552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmic Risk Stratification in Cardiac Amyloidosis: A Review of the Current Literature.
    Bonvicini E; Preda A; Tognola C; Falco R; Gidiucci R; Leo G; Vargiu S; Varrenti M; Gigli L; Baroni M; Carbonaro M; Colombo G; Maloberti A; Giannattasio C; Mazzone P; Guarracini F
    J Cardiovasc Dev Dis; 2024 Jul; 11(7):. PubMed ID: 39057642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.